{"id":37042,"date":"2023-09-27T01:11:22","date_gmt":"2023-09-26T23:11:22","guid":{"rendered":"http:\/\/www.infokuryr.cz\/n\/?p=37042"},"modified":"2023-09-27T03:25:35","modified_gmt":"2023-09-27T01:25:35","slug":"umela-inteligence-otevira-ve-farmaceutickem-prumyslu-nevidane-prilezitosti-k-rustu","status":"publish","type":"post","link":"https:\/\/www.infokuryr.cz\/n\/2023\/09\/27\/umela-inteligence-otevira-ve-farmaceutickem-prumyslu-nevidane-prilezitosti-k-rustu\/","title":{"rendered":"Um\u011bl\u00e1 inteligence otev\u00edr\u00e1 ve farmaceutick\u00e9m pr\u016fmyslu nev\u00eddan\u00e9 p\u0159\u00edle\u017eitosti k r\u016fstu"},"content":{"rendered":"
<\/div>\n

Na urychlen\u00ed v\u00fdvoje l\u00e9k\u016f p\u016fjde a\u017e 50 miliard dolar\u016f ro\u010dn\u011b<\/strong><\/span><\/p>\n

Zat\u00edmco dnes se um\u011bl\u00e1 inteligence prosazuje ve zdravotnictv\u00ed kv\u016fli p\u0159\u00edsn\u00e9 regulaci a obav\u00e1m o bezpe\u010dnost pacient\u016f jen zt\u011b\u017eka, do budoucna by mohla p\u0159in\u00e9st do odv\u011btv\u00ed doslova revoluci. Nap\u0159\u00edklad v podob\u011b v\u00fdrazn\u00e9ho urychlen\u00ed v\u00fdvoje nov\u00fdch l\u00e9k\u016f. Jejich uveden\u00ed na trh dnes m\u016f\u017ee trvat i deset a v\u00edce let a m\u00edra ne\u00fasp\u011bchu b\u011bhem klinick\u00e9ho v\u00fdzkumu \u010dasto dosahuje 90 %. AI v\u0161ak m\u00e1 podle expert\u016f spole\u010dnosti Atradius z\u00a0divize Pharmaceuticals mimo\u0159\u00e1dn\u00fd potenci\u00e1l tyto statistiky od z\u00e1klad\u016f zm\u011bnit.<\/strong><\/p>\n

Zdravotnictv\u00ed a farmaceutick\u00fd pr\u016fmysl pat\u0159\u00ed u\u017e dnes k nejinovativn\u011bj\u0161\u00edm odv\u011btv\u00edm ekonomiky. V\u00fdrobci l\u00e9k\u016f d\u00e1vaj\u00ed na v\u00fdzkum a v\u00fdvoj v pr\u016fm\u011bru 25 % sv\u00fdch p\u0159\u00edjm\u016f. P\u0159esto si pacienti mus\u00ed n\u011bkdy po\u010dkat i v\u00edce ne\u017e 10 let, ne\u017e se k nim nov\u00fd p\u0159\u00edpravek dostane. N\u00e1roky na bezpe\u010dnost jsou tak vysok\u00e9, \u017ee a\u017e dev\u011bt z deseti nov\u011b vyv\u00edjen\u00fdch l\u00e9k\u016f nav\u00edc ztroskot\u00e1 u\u017e ve f\u00e1zi klinick\u00e9ho v\u00fdzkumu. Na obzoru je ale technologie, je\u017e m\u00e1 potenci\u00e1l odv\u011btv\u00ed zcela transformovat a pen\u00edze, je\u017e do n\u011bj proud\u00ed, vyu\u017e\u00edt n\u00e1sobn\u011b efektivn\u011bji. Jde o um\u011blou inteligenci.<\/p>\n

AI si dnes do zdravotnictv\u00ed nach\u00e1z\u00ed cestu p\u0159edev\u0161\u00edm v oblasti monitorov\u00e1n\u00ed a l\u00e9ka\u0159sk\u00e9ho zobrazov\u00e1n\u00ed – jde nap\u0159\u00edklad o podporu l\u00e9ka\u0159\u016f p\u0159i anal\u00fdze sn\u00edmk\u016f z po\u010d\u00edta\u010dov\u00fdch tomograf\u016f \u010di\u00a0jin\u00fdch podobn\u00fdch za\u0159\u00edzen\u00ed. S ohledem na riziko chyby a obavy z mo\u017en\u00fdch dopad\u016f na lidsk\u00e9 zdrav\u00ed je ale jej\u00ed n\u00e1stup pomalej\u0161\u00ed ne\u017e v jin\u00fdch odv\u011btv\u00edch. Nejv\u011bt\u0161\u00ed potenci\u00e1l zm\u011bnit to, a otev\u0159\u00edt tak AI stavidla do zdravotnictv\u00ed jako celku, m\u00e1 nyn\u00ed farmaceutick\u00fd sektor. Podle pr\u016fzkumu spole\u010dnosti Morgan Stanley by mohl v nadch\u00e1zej\u00edc\u00ed dek\u00e1d\u011b na urychlen\u00ed v\u00fdvoje l\u00e9k\u016f pomoc\u00ed um\u011bl\u00e9 inteligence vynakl\u00e1dat a\u017e 50 miliard dolar\u016f ro\u010dn\u011b. Krom\u011b r\u016fstu zisk\u016f firem v\u00a0tomto odv\u011btv\u00ed by to mohlo p\u0159in\u00e9st tak\u00e9 nov\u00e9 a inovativn\u00ed zp\u016fsoby l\u00e9\u010dby pro pacienty. A to zp\u016fsobem, kter\u00fd je\u00a0rychlej\u0161\u00ed a lep\u0161\u00ed ne\u017e kdykoli p\u0159edt\u00edm.<\/p>\n

\u010c\u00edna je na za\u010d\u00e1tku nov\u00e9 \u00e9ry<\/strong><\/span><\/p>\n

Prvn\u00ed n\u00e1znaky toho, \u017ee vyu\u017eit\u00ed um\u011bl\u00e9 inteligence ve farmaceutick\u00e9m pr\u016fmyslu za\u010d\u00edn\u00e1 nab\u00edrat na obr\u00e1tk\u00e1ch, p\u0159ich\u00e1zej\u00ed z \u010c\u00edny. Ke konci roku 2022 tam p\u016fsobilo ji\u017e t\u00e9m\u011b\u0159 80 za\u010d\u00ednaj\u00edc\u00edch (startupov\u00fdch) farmaceutick\u00fdch firem. \u201eInvestice do \u010d\u00ednsk\u00e9ho farmaceutick\u00e9ho pr\u016fmyslu loni dos\u00e1hly 25 miliard dolar\u016f. To sice proti roku 2021 p\u0159edstavuje pokles skoro o polovinu, ale d\u016fvodem byla hlavn\u011b opat\u0159en\u00ed proti \u0161\u00ed\u0159en\u00ed Covid-19. Vzhledem ke st\u00e1vaj\u00edc\u00edmu znovuotev\u0159en\u00ed \u010c\u00edny po pandemii se v roce 2023 o\u010dek\u00e1v\u00e1 n\u00e1vrat k r\u016fstu,<\/em>“ \u0159\u00edk\u00e1 Judi Ji, expertka spole\u010dnosti Atradius <\/strong>z\u00a0divize <\/strong>Pharmaceuticals pro asijsko-pacifickou oblast.<\/strong><\/p>\n

Partnerstv\u00ed mezi farmaceutick\u00fdmi podniky a spole\u010dnostmi zam\u011b\u0159en\u00fdmi na um\u011blou inteligenci \u010di\u00a0big data vznikaj\u00ed st\u00e1le \u010dast\u011bji tak\u00e9 v Evrop\u011b a USA. \u201eSpolupr\u00e1ce americk\u00fdch spole\u010dnost\u00ed Amazon Web Services (AWS), Pfizer a Merck s evropskou AstraZeneca a izraelskou Teva Pharmaceuticals vy\u00fastila v zalo\u017een\u00ed laborato\u0159\u00ed AION Labs. Ty budou zaji\u0161\u0165ovat AI a v\u00fdpo\u010detn\u00ed kapacity a vyv\u00edjet nov\u00e9 farmaceutick\u00e9 postupy. AWS z\u00e1rove\u0148 ned\u00e1vno p\u0159edstavila iniciativu AWS Generative AI Innovation Center. C\u00edlem projektu v hodnot\u011b 100 milion\u016f dolar\u016f je urychlen\u00ed zav\u00e1d\u011bn\u00ed um\u011bl\u00e9 inteligence v podnikov\u00e9 sf\u00e9\u0159e,\u201c<\/em> popisuje Patrick Scardina, odborn\u00edk spole\u010dnosti Atradius <\/strong>z\u00a0divize <\/strong>Pharmaceuticals pro Severn\u00ed a Ji\u017en\u00ed Ameriku.<\/strong><\/p>\n

N\u011bkter\u00e9 p\u0159edn\u00ed farmaceutick\u00e9 spole\u010dnosti dokonce buduj\u00ed vlastn\u00ed t\u00fdmy zam\u011b\u0159en\u00e9 na um\u011blou inteligenci tak, aby udr\u017eovaly pokro\u010dilou technologii a s n\u00ed spojen\u00e1 data zcela mimo dosah konkurence. Pozadu ale nez\u016fst\u00e1vaj\u00ed ani za\u010d\u00ednaj\u00edc\u00ed podniky a men\u0161\u00ed firmy. Nap\u0159\u00edklad n\u00e1stroj start-upu ChatGPT pro zpracov\u00e1n\u00ed p\u0159irozen\u00e9ho jazyka poh\u00e1n\u011bn\u00fd um\u011blou inteligenc\u00ed z\u00edskal investici ve\u00a0v\u00fd\u0161i 175 milion\u016f dolar\u016f, aby pomohl transformovat zdravotnictv\u00ed a v\u011bdu. Podle v\u00fdzkumn\u00edk\u016f z\u00a0Massachusettsk\u00e9 v\u0161eobecn\u00e9 nemocnice a Ansible Health je tak robustn\u00ed, \u017ee ji\u017e nyn\u00ed dok\u00e1\u017ee slo\u017eit l\u00e9ka\u0159skou licen\u010dn\u00ed zkou\u0161ku ve Spojen\u00fdch st\u00e1tech.<\/p>\n

Celosv\u011btov\u00fd trh s um\u011blou inteligenc\u00ed ve zdravotnictv\u00ed dos\u00e1hl v roce 2022 odhadovan\u00e9 hodnoty 15,1 miliardy dolar\u016f. Do roku 2030 by se podle expert\u016f mohl zv\u011bt\u0161it a\u017e 12kr\u00e1t na v\u00edce ne\u017e 185\u00a0miliard dolar\u016f.<\/p>\n

\"\"<\/p>\n

Konkurence velk\u00fdm firm\u00e1m a zm\u011bny v\u00a0regulaci<\/strong><\/span><\/p>\n

Um\u011bl\u00e1 inteligence v\u0161ak p\u0159in\u00e1\u0161\u00ed tradi\u010dn\u00edm farmaceutick\u00fdm firm\u00e1m nejen nov\u00e9 p\u0159\u00edle\u017eitosti, ale p\u0159edstavuje pro n\u011b tak\u00e9 rostouc\u00ed konkurenci. U\u017e dnes jsou na trhu nositeln\u00e1 za\u0159\u00edzen\u00ed monitoruj\u00edc\u00ed v\u0161e od hladiny gluk\u00f3zy v krvi a\u017e po srde\u010dn\u00ed tep. \u0158adu z nich vyr\u00e1b\u00ed technologick\u00e9 korporace jako Google nebo Amazon, pro kter\u00e9 je tato oblast novinkou.<\/p>\n

Rychl\u00fd rozvoj um\u011bl\u00e9 inteligence klade vysok\u00e9 n\u00e1roky tak\u00e9 na regulaci, kterou m\u00e1 naprost\u00e1 v\u011bt\u0161ina zem\u00ed v oblasti zdravotnictv\u00ed velmi p\u0159\u00edsnou. Legislativn\u00ed prost\u0159ed\u00ed se ale n\u00e1stupu AI postupn\u011b p\u0159izp\u016fsobuje. Nap\u0159\u00edklad \u010c\u00edna loni zru\u0161ila omezen\u00ed t\u00fdkaj\u00edc\u00ed se diagnostick\u00fdch technologi\u00ed s\u00a0podporou um\u011bl\u00e9 inteligence, co\u017e umo\u017enilo \u0161ir\u0161\u00ed vyu\u017eit\u00ed AI mimo nemocni\u010dn\u00ed prost\u0159ed\u00ed. \u201ePro samotnou l\u00e9\u010dbu s pomoc\u00ed um\u011bl\u00e9 inteligence nicm\u00e9n\u011b \u010c\u00edna zat\u00edm p\u016fvodn\u00ed pravidla zachovala. Sv\u011bd\u010d\u00ed to o vysok\u00e9 m\u00ed\u0159e nejistoty a obav\u00e1ch z rizik, je\u017e m\u00e1 dohled \u00fa\u0159ad\u016f udr\u017eet pod kontrolou,<\/em>\u201d popisuje Judy Ji.<\/p>\n

Tak\u00e9 \u00fa\u0159ady v Evrop\u011b ji\u017e kontroluj\u00ed pou\u017e\u00edv\u00e1n\u00ed um\u011bl\u00e9 inteligence ve v\u011bt\u0161in\u011b aplikac\u00ed v\u010detn\u011b farmaceutick\u00fdch. \u201eObavy EU souvis\u00ed mimo jin\u00e9 s ot\u00e1zkami ochrany soukrom\u00ed p\u0159i tr\u00e9nov\u00e1n\u00ed AI\u00a0na\u00a0vstupu a s p\u0159edpojatost\u00ed v rozhodnut\u00edch nebo n\u00e1vrz\u00edch AI na v\u00fdstupu,“<\/em> vysv\u011btluje Rub\u00e9n del R\u00edo Hern\u00e1ndez, kter\u00fd v poji\u0161\u0165ovn\u011b Atradius <\/strong>v\u00a0divizi<\/strong> Pharmaceuticals odpov\u00edd\u00e1 za region Evropy<\/strong>.<\/p>\n

Rizika pro men\u0161\u00ed podniky<\/strong><\/span><\/p>\n

Brzdu rychlej\u0161\u00edho pronik\u00e1n\u00ed AI do farmaceutick\u00e9ho pr\u016fmyslu p\u0159edstavuj\u00ed krom\u011b regulace tak\u00e9 n\u00e1klady. Ty jsou s ohledem na nutn\u00e9 investice do v\u00fdzkumu a v\u00fdvoje v oboru vysok\u00e9 u\u017e nyn\u00ed. Um\u011bl\u00e1 inteligence a s n\u00ed spojen\u00e9 nov\u00e9 technologie n\u00e1roky na financov\u00e1n\u00ed je\u0161t\u011b nav\u00fd\u0161\u00ed, co\u017e m\u016f\u017ee z trhu postupn\u011b vy\u0159adit men\u0161\u00ed firmy. Ty jsou p\u0159itom \u010dasto ve srovn\u00e1n\u00ed s korporacemi flexibiln\u011bj\u0161\u00ed, dynami\u010dt\u011bj\u0161\u00ed a rychleji se p\u0159izp\u016fsobuj\u00ed vn\u011bj\u0161\u00edm podm\u00ednk\u00e1m.<\/p>\n

Zaj\u00edmav\u00e9 firmy, je\u017e nebudou m\u00edt dostatek vlastn\u00edch zdroj\u016f k pln\u00e9mu vyu\u017eit\u00ed um\u011bl\u00e9 inteligence, se\u00a0podle Hernand\u00e9ze mohou st\u00e1t akvizi\u010dn\u00edm c\u00edlem velk\u00fdch farmaceutick\u00fdch spole\u010dnost\u00ed. Mal\u00e9 firmy s n\u00edzk\u00fdm potenci\u00e1lem v\u0161ak pravd\u011bpodobn\u011b skon\u010d\u00ed – mimo jin\u00e9 i proto, \u017ee do odv\u011btv\u00ed d\u00edky rostouc\u00edm v\u00fdznamu AI budou p\u0159ich\u00e1zet nov\u00ed hr\u00e1\u010di. Nap\u0159\u00edklad pro technologick\u00e9 giganty je\u00a0zdravotnictv\u00ed atraktivn\u00ed proto, \u017ee p\u0159edstavuje velk\u00fd a dlouhodob\u011b udr\u017eiteln\u00fd trh. V\u0161ichni lid\u00e9 cht\u011bj\u00ed \u017e\u00edt l\u00e9pe a d\u00e9le a l\u00e9ky \u010di l\u00e9\u010debn\u00e9 postupy k tomu pot\u0159ebuj\u00ed.<\/p>\n

Krom\u011b technologick\u00fdch spole\u010dnost\u00ed se nav\u00edc o oblast zdravotnictv\u00ed st\u00e1le v\u00edce zaj\u00edmaj\u00ed tak\u00e9 potravin\u00e1\u0159sk\u00e9 firmy, v\u00fdrobci kosmetick\u00fdch p\u0159\u00edpravk\u016f, poskytovatel\u00e9 wellness slu\u017eeb a s ohledem na rozvoj telemedic\u00edny rovn\u011b\u017e telekomunika\u010dn\u00ed oper\u00e1to\u0159i. Tak\u00e9 banky a poji\u0161\u0165ovny ji\u017e p\u0159ipravuj\u00ed programy prevence spojen\u00e9 s monitorov\u00e1n\u00edm zdrav\u00e9ho \u017eivotn\u00edho stylu.<\/p>\n

A\u010dkoli se zat\u00edm nov\u00ed hr\u00e1\u010di zam\u011b\u0159uj\u00ed sp\u00ed\u0161e na zdravotn\u00ed p\u00e9\u010di, ne\u017e aby zvy\u0161ovali konkurenci p\u0159\u00edmo farmaceutick\u00fdm firm\u00e1m, mnoz\u00ed z nich disponuj\u00ed velk\u00fdm mno\u017estv\u00edm voln\u00fdch pen\u011bz. Budou tak schopni z\u00edsk\u00e1vat farmaceutick\u00e9 nebo biotechnologick\u00e9 spole\u010dnosti formou akvizic. Na obzoru se tud\u00ed\u017e r\u00fdsuj\u00ed zaj\u00edmav\u00e9 synergie mezi technologick\u00fdm sektorem a farmaci\u00ed. Velk\u00e9 farmaceutick\u00e9 spole\u010dnosti by se proto m\u011bly m\u00edt na pozoru.<\/p>\n

O spole\u010dnosti Atradius<\/strong><\/span><\/p>\n

Atradius pat\u0159\u00ed mezi celosv\u011btov\u00e9 l\u00eddry v oblasti poji\u0161t\u011bn\u00ed pohled\u00e1vek, poskytov\u00e1n\u00ed z\u00e1ruk a\u00a0vym\u00e1h\u00e1n\u00ed pohled\u00e1vek. P\u016fsob\u00ed v 54 zem\u00edch po cel\u00e9m sv\u011bt\u011b, ve kter\u00fdch se m\u016f\u017ee spolehnout na v\u00edce ne\u017e 160 vlastn\u00edch pobo\u010dek a 3 400 zam\u011bstnanc\u016f. Sv\u00fdm z\u00e1kazn\u00edk\u016fm umo\u017e\u0148uje p\u0159\u00edstup k\u00a0informac\u00edm a\u017e o 240 milionech firem. Na \u010desk\u00e9m trhu p\u016fsob\u00ed Atradius od roku 1998 a\u00a0v\u00a0sou\u010dasnosti z \u010cesk\u00e9 republiky \u0159\u00edd\u00ed strategick\u00e9 projekty pro cel\u00fd region v\u00fdchodn\u00ed Evropy. Spole\u010dnost Atradius je sou\u010d\u00e1st\u00ed skupiny Grupo Catalana Occidente (GCO.MC) – jedn\u00e9 z\u00a0celosv\u011btov\u011b nej\u00fasp\u011b\u0161n\u011bj\u0161\u00edch poji\u0161\u0165oven poskytuj\u00edc\u00edch poji\u0161t\u011bn\u00ed \u00fav\u011br\u016f. V\u00edce informac\u00ed naleznete online na adrese www.atradius.cz<\/a>.<\/p>\n

 <\/p>\n

 <\/p>\n

\"\"<\/a><\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Na urychlen\u00ed v\u00fdvoje l\u00e9k\u016f p\u016fjde a\u017e 50 miliard dolar\u016f ro\u010dn\u011b Zat\u00edmco dnes se um\u011bl\u00e1 inteligence…<\/p>\n","protected":false},"author":2,"featured_media":37044,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[6],"tags":[3101,1020,1867,2009],"_links":{"self":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts\/37042"}],"collection":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/comments?post=37042"}],"version-history":[{"count":0,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts\/37042\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/media\/37044"}],"wp:attachment":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/media?parent=37042"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/categories?post=37042"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/tags?post=37042"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}